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Background: Hypovitaminosis D has previously been reported in both the general population, in people with
chronic musculoskeletal pain, and in people with low back pain (LBP). Myopathy-related symptoms such as diffuse
bone and muscle pain, weakness and paresthesia in the legs, have also been observed in people with non-specific
LBP and associations with low levels of Vitamin D have been suggested. The objectives of this study were to
investigate (1) Vitamin D levels in patients seeking care for LBP in a Danish out-patient secondary care setting, and
(2) their possible relationship with myopathy-related symptoms, Body Mass Index (BMI), and Modic changes.
Methods: A total of 152 consecutive patients with non-specific LBP participated in a cross-sectional study.
Participants were recruited at The Spine Centre of Southern Denmark during springtime 2011. Individual serum
levels of 25-Hydroxyvitamin-D were determined using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/
MS). Information about symptoms, height, and weight were collected from electronic questionnaires completed by
the participants. All patients had an MRI from which Modic changes were identified. Correlations between Vitamin
D level and pain, paresthesia, weakness in the legs, BMI or Modic changes were described using correlation
coefficients and odds ratios obtained from logistic regression.
Results: Two-thirds of the included patients with LBP had normal Vitamin D levels of >50 nmol/L. No correlations
were seen between Vitamin D deficiency and gender, age, back pain intensity, leg pain intensity, and duration of
pain. Statistically significant, but low, correlation coefficients were found between Vitamin D levels and BMI as well
as Modic changes. Low Vitamin D levels and Modic changes were statistically significantly associated with an odds
ratio of 0.30 (95% CI 0.12; 0.75) while weakness, paresthesia and widespread pain were not.
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Conclusions: In patients seeking care for low back pain in a Danish outpatient clinic, Vitamin D deficiency was not
common. Whether patients who are overweight or who have Modic changes might represent subgroups of people
for whom their LBP may be associated with Vitamin D levels, needs further investigation.
Keywords: Low back pain, Vitamin D, Modic changesBackground
Internationally, there is consensus to define low back
pain (LBP) as pain localised in the area below the costal
margins and above the inferior gluteal folds [1]. LBP can
be accompanied by leg pain (sciatica) or paresthesia in
the legs. Forming a definitive patho-anatomical diagnosis
in LBP is often difficult and is only possible in approxi-
mately 20% of patients attending primary care. The
remaining 80% are often diagnosed with non-specific
LBP [2]. The search for patho-anatomical causes of LBP
is ongoing despite the fact that LBP is regarded as a
multifactorial problem [3].
One line of research has investigated Modic changes
as a potential cause of LBP. Dr. Modic and his group
defined these as signal changes in the vertebral end
plates seen on Magnetic Resonance Imaging (MRI) [4].
According to their definitions, the first stage is referred
to as Type 1, which reflects hyper-vascularity in the
vertebrae, probably as a result of inflammation. Type 2
consists of fatty replacements of the red bone marrow
in the vertebrae. Modic changes seem to be associated
with LBP and might constitute a patho-anatomical
cause of LBP [5,6]. A systematic review by Jensen et al.
showed a median prevalence of Modic changes of 43%
in patients with non-specific LBP in contrast to a
median prevalence of 6% in non-clinical populations [5],
but the patho-genetic mechanisms underlying Modic
changes are not completely understood [7]. It has been
suggested that a possible cause of Modic changes is disc
degeneration causing increased shear forces on the lum-
bar vertebral end plates leading to micro fractures.
Modic changes could be either oedema-initialised by
end plate micro fractures or an inflammatory response
caused by pro-inflammatory chemicals seeping from the
nucleus pulposus through such micro fractures [7].
Another line of research has drawn attention to Vitamin
D and its relationship to the prevention of lifestyle-related
diseases and inflammatory diseases [8,9]. Previous studies
suggest that Vitamin D may be important in preventing
Type 1-diabetes, cardiovascular heart disease, auto-immune
diseases, depression and some cancers [8,10,11]. Vitamin D
has also been suggested to have anti-inflammatory proper-
ties and has been shown to decrease pro-inflammatory
cytokines and increase anti-inflammatory cytokines [9,12].
Several authors have suggested Vitamin D deficiency as a
possible cause of chronic musculoskeletal pain [8,9].Furthermore, Vitamin D has the ability to function as a
hormone in the human body [9]. Its major function is to
maintain calcium homeostasis. It is vital for development
and maintenance of a healthy skeleton throughout life
[9,13], and for maintaining optimal functioning of the
muscles and nervous system [14,15].
Vitamin D deficiency is well documented worldwide
[8,16], and is a common disorder in many regions,
regardless of latitude [8,9,16-19]. Hypovitaminosis D
has been reported in populations with several different
types of chronic musculoskeletal pain such as osteoarthritis,
rheumatoid arthritis, osteoporosis, soft tissue rheumatism,
LBP, and arthralgia [9,17,19-23]. The reported musculo-
skeletal manifestations are diffuse muscle pain and weak-
ness, muscle fatigue, paresthesia, arthralgia, and deep
bone pain. These myopathic and arthralgic symptoms are
non-specific and difficult to link to a specific diagnosis
that may lead to other diagnoses such as fibromyalgia,
polymyalgia and non-specific rheumatic diseases [14]. In
clinical settings, adult patients with non-specific LBP often
report accompanying diffuse musculoskeletal symptoms
similar to those associated with Hypovitaminosis D as
suggested above.
Therefore, we hypothesised that Danish people with
non-specific LBP suffer from Vitamin D deficiency, as pre-
viously reported in both Egyptian and Saudi Arabian LBP
populations [20,23], and that accompanying symptoms of
diffuse pain in the back and legs, weakness, paresthesia,
and Modic changes were related to Vitamin D deficiency.
Theoretically, there are two possible links between
Hypovitaminosis D and LBP. Firstly, in patients with LBP,
the diffuse pain in bone and muscle, weakness and
paresthesia may be caused by Hypovitaminosis D. Sec-
ondly, Hypovitaminosis D could play a role in the develop-
ment of Modic changes via the increased susceptibility to
inflammation in the vertebral end plates [7]. Furthermore,
low levels of Vitamin D cause increased serum parathyroid
hormone leading to an increased bone turnover, which
increases the risk of micro fractures in the vertebrae [24].
To our knowledge, no study exists on either the associ-
ation between LBP and Vitamin D in northern latitude
settings or possible associations between Vitamin D defi-
ciency and the development of myopathy-related symp-
toms or Modic changes in LBP patients. Such knowledge
may lead to new insights into the understanding and treat-
ment of people suffering from LBP and the definition of a
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specific clinical characteristics.
The objectives of this study were: (1) to describe the
levels of serum Vitamin D in Danish patients with non-
specific LBP, (2) to investigate how Vitamin D levels
were related to the month of investigation, gender, age,
BMI, duration of LBP, level of recent LBP, level of recent
leg pain, number of pain sites, type of Modic changes,
and (3) to examine possible associations between Vita-
min D deficiency and Modic changes, muscle weakness,
paresthesia and widespread pain.
Methods
Study design
The study was a cross-sectional cohort study of con-
secutive patients with non-specific LBP with or without
leg pain seeking care in a Danish secondary out-patient
hospital setting.
Study population
Participants were recruited from patients referred to
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Patients were excluded if they had contra-indications for
lumbar spine MRI (ferromagnetic implants, claustropho-
bia etc.), or specific diagnosis of disc herniation, spinal
stenosis, spondylolisthesis with spondylolysis, nerve root
compression, fracture or metastases observable on MRI.
Procedures
The project leader (JVJ) screened all new referrals during
the data collection period for patients fulfilling the inclu-
sion criteria prior to their first visit at The Spine Centre.
Patients who met the inclusion criteria were invited to
participate in the study and, after having received oral and
written information about the study, the participating pa-
tients gave their written consent. The Ethics Committee
of Southern Denmark approved the study (Project ID: S-
20110032). The Database Access Committee granted ac-
cess to information on the participants collected in
SpineData. The flow of participants is shown in Figure 1.
On arrival at The Spine Centre, each participant com-
pleted an electronic questionnaire that was stored in the
SpineData database. For the analysis in this study, we
used the variables listed and defined in Table 1.
Blood samples were taken on the same day by laboratory
technicians at Lillebaelt Hospital, Middelfart. One sampleTable 1 Descriptions and definitions of variables
Variable Provision of data and definition
The variables marked a have been extracted from t
Vitamin D level Measured by blood sample: Serum 25-Hydroxyvitamin-
Results divided into 3 groups: (1) normal Vitamin D lev
and (3) severe/moderate Vitamin D deficiency < 25 nm
Levels were measured in March, April and May 2011
Body mass index,
BMI a
Calculated from self-reported height (h) and weight fro
Formula: BMI =mass (kg)/height2 (m)
Low Back Pain,
LBP a
Pain intensity, (0–10 numerical rating scales). Self-repor
Patients were asked to enter: (1) back pain now, (2) wo
LBP intensity is an average of the three entered scores
Leg paina Pain intensity, (0–10 numerical rating scales). Self-repor
Patients were asked to enter: (1) leg pain now, (2) wors
Leg pain intensity is an average of the three entered sc
Modic changes Defined as signal changes in the vertebral end plates d
descriptions.
Modic changes were divided into groups: (1) No modi
Modic Type 2 and (4) Modic Types 1 and 2
Weakness in legs a Patients were asked about any weakness in the legs. Se
Paresthesia in legs a Patients were asked about any paresthesia in the legs.
Widespread pain a Patients reported their pain on a pain chart. In the data
database to calculate the number of pain regions
a Patients completed an electronic version of the SpineData questionnaire which in
worst and average) the last two weeks, pain days per week, symptoms in the legs,
pain, function (Roland Morris Disability Questionnaire), quality of life (EuroQOL-5D),
use of medication). All data are self-reported.was taken to analyse serum 25-Hydroxyvitamin-D,
which has been suggested to be the best marker for
measuring Vitamin D levels [9,18]. Blood samples were
handled according to standard protocols and sent for
analysis to the Department of Clinical Biochemistry in
Vejle. Liquid Chromatography Tandem Mass Spectrometry
(LC-MS/MS) was used for determining serum 25-
Hydroxyvitamin-D.
Definition of Vitamin D deficiency
In this study, we used the definition of Vitamin D defi-
ciency suggested by Lips and the Danish recommenda-
tions from the National Food Institute [27,28]. Reference
values were divided into four groups: (1) >50 nmol/L =
normal, (2) 25–50 nmol/L =mild deficiency, (3) 12.5-25
nmol/L =moderat deficiency, and (4) <12.5 nmol/L =
severe deficiency.
Statistical analysis
A pre-hoc sample size calculation was performed for a
single-group study and was based on the results from a
previous study of chronic musculoskeletal pain in a
Caucasian population and Hypovitaminosis D [19]. As
we expected to have similar outcomes, the descriptive
parameters (mean 35 nmol/L, standard deviation (SD) 18,he SpineData database at The Spine Centre of Southern Denmark
D specified in nmol/L
el > 50 nmol/L, (2) mild Vitamin D deficiency between 25–50 nmol/L,
ol/L [14]
m the database.
ted from the database.
rst back pain last two weeks and (3) average back pain last two weeks.
[25]
ted from the database.
t leg pain last two weeks and (3) average leg pain last two weeks.
ores [25].
iagnosed on MRI [26] (Jensen, 2007). Data obtained from MRI
c, (2) Modic Type 1, (3)
lf-reported from the database (yes/no)
Self -reported from the database (yes/no)
base, the chart is divided into 46 different pain sites, which enables the
cluded a number of questions relevant to the current LBP episode: Pain (now,
previous back/neck pain, date of onset and the triggering factor of present
general health (0–100 EuroQOL health thermometer, work situation and the
Table 2 Characteristics of the LBP patients
Descriptive statistics Values
Age (years) n = 152 44.6 ± 11.2 (19–64)
Mean ± SD (range)
Gender n = 152 ♀ 100 (66%)
Female ♀/male ♂ (%) ♂ 52 (34%)
Body Mass Index, BMI n = 138 26.0 ± 4.5 (18.9-38.9)
Mean ± SD (range)
LBP a n = 146 6.0 ± 2.0 (0.0-10)
Mean ± SD (range)
Leg pain a n = 146 4.1 ± 3.0 (0.0-9.7)
Mean ± SD (range)
Previous LBP episodes n = 143 107 (74.8%)
Frequency (%)
Pain days per week: (frequency (%)) n = 144
Less than 1 day per week 2 (1.4%)
1-2 days per week 4 (2.8%)
3-4 days per week 13 (9.0%)
5-6 days per week 12 (8.3%)
Every day 113 (78.5%)
Weakness in legs n = 141 66 (46.8%)
Frequency (%)
Paresthesia in legs n = 142 93 (65.5%)
Frequency (%)
Widespread pain n = 143
Frequency (%)
≤ 5 pain areas 85 (59.4%)
> 5 pain areas 58 (40,6%)
Vitamin D level (nmol/L) n = 152 58.8 ± 26.2 (11–146)
Mean ± SD (range)
Modic changes (frequency (%)) n = 152
No Modic 112 (73.7%)
Modic Type 1 18 (11.8%)
Modic Type 2 13 (8.6%)
Modic Types 1 + 2 9 (5.9%)
a Pain intensity on LBP and leg pain is an average (0–10 numerical rating
scale) based on pain now (0–10), worst pain in the last 2 weeks (0–10) and
average pain last 2 weeks (0–10) [25].
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sample size calculation using an on-line calculator at
Dimension Research [29]. That method recommended a
requirement of 147 patients to ensure adequate power for
this study.
Descriptive data for all variables included in the study
were reported (means, SD and range for continuous
variables; frequencies and proportions for categorical vari-
ables). Distributional graphs were inspected in order to
determine the need for parametric or non-parametric stat-
istical methods. Differences in distributions of descriptive
data in the groups of Vitamin D deficiencies were cross-
tabulated and tested using Fisher’s Exact Test. Correlations
between Vitamin D levels and the variables of interest were
visualised in scatter plots and further investigated using
a Pearson correlation coefficient for continuous and
normally distributed data and a Spearman correlation
coefficient for categorical data and non-normally distrib-
uted data. Associations between low Vitamin D levels and
clinical variables of interest were expressed as odds ratios
with 95% CI obtained from logistic regression. For these
analyses, the outcome variable (reduced Vitamin D) and
explanatory variables (Modic changes yes/no, muscle
weakness, paresthesia, and widespread pain if number of
pain sites was > 5) were dichotomised.
The statistical software Stata/IC11.1 (StataCorp, Lakeway
Drive, College Station, Texas USA) was used for the
statistical analysis.
Results
A total of 902 new referrals to The Spine Centre were
screened for possible participation and 152 patients en-
tered the study. Figure 1 shows the flow of patients and
the reasons for non-participation. The participants in-
cluded 100 women and 52 men aged between 19 and 64 -
years (mean 44.6 years). Other demographic information
is given in Table 2.
Only one patient had severe Vitamin D deficiency.
Therefore, the categories ‘severe deficiency’ and ‘moderate
deficiency’ were combined into one (severe/moderate
deficiency < 25 nmol/L) for subsequent analysis. Most
patients (99 (65.1%) of the 152 patients) had normal
Vitamin D levels above 50 nmol/L, 36 (23.7%) had mild
Vitamin D deficiency between 25–50 nmol/L, and 17
(11.2%) patients had moderate/severe deficiency < 25 -
nmol/L. The mean for Vitamin D levels for all patients
was 58.8 nmol/L (SD 26.2).
Vitamin D levels increased during the 3-month inves-
tigation. In March, the mean Vitamin D levels in 22
new patients were 54.8 nmol/L ± 32.2 SD, range 18–
146 nmol/L; in April, in 53 new patients were 56.5
nmol/L ± 28.5 SD, range 11–124 nmol/L; and in May, in
77 new patients were 61.6 nmol/L ± 22.4 SD, range 15–
109 nmol/L; however, the increase was not statisticallysignificant. The median and interquartile ranges are
given in Figure 2.
In total, 40 (26.3%) patients had Modic changes of which
18 (11.8%) had Type I, 13 (8.6%) had Type II and 9 (5.9%)
had both Modic Types I and II. In the group of patients
with normal Vitamin D levels (n = 99), 33 (33.3%) patients
had Modic changes. In the group with a mild deficiency
(n = 36), 5 (13.9%) patients had Modic changes and in
the group with a moderate/severe deficiency (n = 17), 2
(11.8%) patients had Modic changes. The median values
Figure 2 Vitamin D level by month (median, interquartile range).
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and descriptive statistics are listed in Table 2.
The correlation between Vitamin D levels and gender,
age, BMI, duration of current episode, recent LBP, recent
leg pain, number of pain regions and Modic changes are
shown in Figure 3. Cross tabulating these variables, with
the three groups of Vitamin D levels showed no statisti-
cally significant differences in distribution (data not
shown). Only BMI and Modic changes were significantly
correlated with Vitamin D level (rp = −0.233, p = 0.006 and
rs = 0.221, p = 0.006 respectively, data not shown).
Only Modic changes were statistically significantly asso-
ciated with low Vitamin D levels but in an inverse manner:
Modic changes appeared to be protective of low Vitamin
D level with an odds ratio of 0.30 (95%CI 0.12;0.75).
Paresthesia, weakness and widespread pain were not
associated with low Vitamin D (see Table 3).
Discussion
This was the first study to investigate Vitamin D levels
in patients living in northern latitudes who were seeking
care in an outpatient clinic for their LBP. These patients
had Vitamin D levels comparable to those in the general
population in Denmark. Therefore, our hypothesis was
not supported. Firstly, low levels of Vitamin D were
not related to the clinical symptoms. Secondly, Modic
changes were less common in people with low levels of
Vitamin D. The current study could not support the
existence of a specific subgroup that would benefit from
treatment aimed at normalising Vitamin D levels.
The results of this study show that Vitamin D defi-
ciency is not common in LBP patients, who are similar
to those included in this study. The trend of an increase
in Vitamin D levels from March until May is consistentwith people being exposed to more sunlight during the
northern Europe spring [16,18]. Vitamin D levels of LBP
patients in the current study reflect those observed in
the general Danish population. Mean Vitamin D levels
of blood donors, who are supposed to be representative
of at least the healthier segment of the general popula-
tion in Denmark, have been reported to be 85 nmol/L
(range: 26–163 nmol/L) in summer and 45 nmol/L
(range: 13–128) in winter [18]. Previous studies by
Glerup et al. have reported mean Vitamin D levels in
healthy Danish women of 47.1 nmol/L (+/− 4.6) in a con-
trol group [30] whereas Brot et al. reported 53.5 nmol/L in
a group of 280 middle-aged women regularly exposed to
sun and not taking vitamin supplements [31].
A sufficient level of Vitamin D in serum is continu-
ously discussed in the literature and it is still subject to
debate [9,10,18]. Previous studies that reported low
levels of Vitamin D in populations with LBP used differ-
ent reference criteria for normal values >100 nmol/L
(>40 ng/ml) [23] and > 22.5 nmol/L [20], which makes
comparison between studies difficult. Haroon et al. inves-
tigated 231 consecutive patients in general clinics using a
reference criterion for a normal value of >53 nmol/L [21].
Of the 231 patients, 8 had backache, 6 (75%) of whom had
Vitamin D deficiency. Our results differ from the findings
of Haroon et al., but comparison is difficult since only
eight patients had backache.
Multiple factors affect the ability to synthesise Vitamin
D, such as latitude, skin pigmentation, clothing, exposure
to sunlight, obesity, malnutrition, and protein deficiency
[13,16,24]. These factors complicate the direct comparison
of Egyptian and Saudi Arabian people with people from
countries in northern latitudes. Individual thresholds exist
for the need for certain minerals and vitamins in humans.
Figure 3 Relationships between Vitamin D levels and variables.
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the development of musculoskeletal symptoms due to a
deficiency in certain minerals and vitamins, including
Vitamin D.
The available methods for analysing 25-OH-D show
significant differences in levels depending on which
method is used [32,33]. Lips et al. compared three
different methods of measuring Vitamin D levels [33]. A
difference of 80% between Competitive Protein Binding
(CPB) assay was seen when compared with High-
Performance Liquid Chromatography (HPLC), while
Radioimmunoassay (RIA) gave intermediate values [33].
The LC-MS/MS method that we used in this study is
reported to be the most reliable method [32]. DespiteTable 3 Association between clinical variables
Variables Odds ratio (CI 95%)
Modic changes 0.30 (0.12;0.75)
Muscle weakness 1.08 (0.54;2.15)
Paresthesia 0.79 (0.38;1.62)
Widespread pain 1.10 (0.55;2.19)
(dichotomised) and Vitamin D deficiency (y/n).this, variability in results between reporting laboratories
can be up to 15% [32].
Our results did not support our hypothesis, and are in
contrast to the findings in several previous studies on
both chronic musculoskeletal pain and LBP, which sug-
gests there might be several musculoskeletal symptoms
related to low levels of Vitamin D [17,19-23]. However,
the lack of association between LBP and low levels of
Vitamin D has been shown previously: Heidari et al.
found significantly lower Vitamin D levels in patients
with non-specific skeletal pain, but, similar to our find-
ings, not in the group of back pain patients [22]. In an-
other study, Lotfi et al. found no associations between
Vitamin D levels and back pain intensity or duration of
LBP [23].
The lack of association we found between widespread
pain and low Vitamin D levels is in contrast to the findings
of McBeth et al. who reported that people with chronic
widespread musculoskeletal pain have a 50% increased risk
of low levels of Vitamin D [17].
We found no association between Vitamin D levels
and myopathy-related symptoms. This could be due to
either a small group of patients in the moderate/severe-
Johansen et al. BMC Musculoskeletal Disorders 2013, 14:78 Page 8 of 9
http://www.biomedcentral.com/1471-2474/14/78group (n = 17 (11%) and only one with severe Vitamin D
deficiency), or the fact that the symptoms were self-
reported and not objectively measured. Glerup et al.
found that most myopathy-related symptoms are
present at Vitamin D levels below 25 nmol/L and that
the first symptom most often reported is fatigue and
not pain or paresthesia [14], which could account for
the lack of association in our study.
Our finding of a negative correlation between Vitamin
D deficiency and high BMI has previously been reported
and can be explained by a storage of Vitamin D in adipose
tissue [9,16,34]. Further investigations aimed at examining
whether there is a relation between LBP, high BMI and
levels of Vitamin D could be interesting in the search for
relevant subgroups within LBP patients.
Unexpectedly, Modic changes were more common in
people with normal levels of Vitamin D compared with
those with low levels. According to our theoretical
framework, people with Modic changes were expected
to have low levels of Vitamin D due to an increased
susceptibility to inflammation [12] and/or to micro-
fractures in the vertebrae due to increased levels of
parathyroid hormone [24]. Only serum 25-OH-D were
measured in this study. Therefore, it is not possible to draw
conclusions about increased bone turnover in the investi-
gated group of LBP patients, although levels of < 50 nmol/L
have been shown to cause an increased level of parathyroid
hormone [24]. Our initial theoretical framework failed
to explain the possible relationship between Vitamin D
and Modic changes. Perhaps, the increased risk of
micro-fractures related to cortical bone due to hyper-
parathyroidism [24] does not apply to the vertebra end
plates, which mainly consist of hyalin cartilage, and
therefore the significant finding was perhaps simply a
random and sample-specific artifact.
The mechanisms in the development of Modic changes
are still not sufficiently known. Current significant find-
ings suggest that there could be a link between Vitamin D
and Modic changes perhaps related to inflammation.
Further studies are needed on the subject.
The strengths of this study are that participants were
recruited from consecutive patients, standardised institu-
tional methods were used for collecting self-reported data,
and blood samples were taken on the same day as filling
in the self-report questionnaires. However, while the in-
cluded patients might be representative of non-specific
LBP patients at The Spine Center of Southern Denmark,
it is not known how comparable they are with patients in
other settings.
Our study does not support an identifiable sub-group
of people with LBP and Vitamin D deficiency who could
benefit from treatment with Vitamin D. This is in line
with a Cochrane review that concludes that there is not
sufficient evidence to support treatment of chronic painwith Vitamin D [35]. The study had a cross-sectional
design. A randomised control trial is needed to further
investigate whether people with non-specific LBP would
benefit from Vitamin D treatment. Furthermore, the
design does not allow us to make conclusions regarding
adequate thresholds of 25 (OH)D in non-specific LPB
patients. This is still a relevant research question.
LBP is a common disorder throughout the world with
two-thirds of all adults experiencing back pain at some
time in their life [36]. The group of non-specific LBP
patients is a heterogeneous group with multiple factors
contributing to the symptoms experienced by the indi-
vidual patient. Many different biological and psycho-
social factors can contribute to LBP symptoms [36,37],
and therefore, it is difficult to isolate a single reason for
non-specific or chronic LBP in a given individual. Perhaps
the underlying mechanisms of non-specific LBP differ
in different regions of the world and perhaps these
mechanisms differ across ethnic groups.
Conclusions
The results of this study indicated that a group of Danish
people with non-specific LBP did not have Vitamin D defi-
ciency, and no relationships were found between those
with Vitamin D deficiency and myopathy-related symp-
toms of weakness and paresthesia in the legs, back pain or
leg pain intensity. LBP patients with Vitamin D deficiency
did not have different clinical characteristics compared
with LBP patients with normal Vitamin D levels. The ob-
servation that LBP patients with Modic changes had rela-
tively higher Vitamin D levels warrants further study.
Abbreviations
LBP: Low back pain; BMI: Body mass index; LC-MS/MS: Liquid
chromatography tandem mass spectrometry; MRI: Magnetic resonance
imaging.
Competing interests
There are no competing interests, either financial or non-financial.
Authors’ contributions
JVJ designed the project, carried out the recruitment of patients, coordinated
the collection of the data, assisted in the interpretation of the data and
drafted the manuscript. CM participated in the design of the project, assisted
in the coordination and the interpretation of the data. PK participated in the
design of the project, performed the statistical analysis, carried out the
interpretation of the data and helped draft the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
We thank the clinicians at The Spine Centre of Southern Denmark for their
assistance in the recruitment of patients and special thanks to Peter Kent and
Lars Morsoe in the Research Department for their contributions to the study.
Author details
1Research Unit, Spine Centre of Southern Denmark, Part of Clinical
Locomotion Network, Hospital Lillebaelt, Institute of Regional Health Services,
University of Southern Denmark, Oestre Hougvej 55, DK-5500, Middelfart,
Denmark. 2Institute of Sports Science and Clinical Biomechanics, Part of
Clinical Locomotion Network, University of Southern Denmark, Odense,
Denmark.
Johansen et al. BMC Musculoskeletal Disorders 2013, 14:78 Page 9 of 9
http://www.biomedcentral.com/1471-2474/14/78Received: 14 November 2012 Accepted: 26 February 2013
Published: 4 March 2013References
1. Dionne CE, Dunn KM, Croft PR, Nachemson AL, Buchbinder R, Walker BF,
Wyatt M, Cassidy JD, Rossignol M, Leboeuf-Yde C, et al: A consensus
approach toward the standardization of back pain definitions for use in
prevalence studies. Spine (Phila Pa 1976) 2008, 33(1):95–103.
2. Deyo RA: Diagnostic evaluation of LBP - reaching a specific diagnosis is
often impossible. Arch Intern Med 2002, 162(13):1444–1447.
3. Waddell G: The Back Pain Revolution. Edinburgh: Chruchill Livingstone; 1998.
4. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR: Degenerative disk
disease: assessment of changes in vertebral body marrow with MR
imaging. Radiology 1988, 166(1 Pt 1):193–199.
5. Jensen TS, Karppinen J, Sorensen JS, Niinimaki J, Leboeuf-Yde C: Vertebral
endplate signal changes (Modic change): a systematic literature review
of prevalence and association with non-specific low back pain. Eur Spine
J 2008, 17(11):1407–1422.
6. Kjaer P, Korsholm L, Bendix T, Sorensen JS, Leboeuf-Yde C: Modic changes
and their associations with clinical findings. Eur Spine J 2006,
15(9):1312–1319.
7. Albert HB, Kjaer P, Jensen TS, Sorensen JS, Bendix T, Manniche C: Modic
changes, possible causes and relation to low back pain. Med Hypotheses
2008, 70(2):361–368.
8. Holick MF, Chen TC: Vitamin D deficiency: a worldwide problem with
health consequences. Am J Clin Nutr 2008, 87(4):1080S–1086S.
9. Leavitt SB: Vitamin D - A neglected ‘analgesic for chronic musculoskeletal
pain. Pain Treatment Topics 2008. Available at [http://pain-topics.org/pdf/
vitamind-report.pdf], access date: 7th February 2013.
10. Holick MF: Vitamin D: important for prevention of osteoporosis,
cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and
some cancers. South Med J 2005, 98(10):1024–1027.
11. Berk M, Sanders KM, Pasco JA, Jacka FN, Williams LJ, Hayles AL, Dodd S:
Vitamin D deficiency may play a role in depression. Medical Hypotheses
2007, 69(6):1316–1319.
12. D’Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R,
Sinigaglia F, Panina-Bordignon P: Inhibition of IL-12 production by 1,25-
dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in
transcriptional repression of the p40 gene. J Clin Invest 1998,
101(1):252–262.
13. Holick MF: Vitamin D: a millenium perspective. J Cell Biochem 2003,
88(2):296–307.
14. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P,
Eriksen EF: Hypovitaminosis D myopathy without biochemical signs of
osteomalacic bone involvement. Calcif Tissue Int 2000, 66(6):419–424.
15. Pfeifer M, Begerow B, Minne HW: Vitamin D and muscle function.
Osteoporos Int 2002, 13(3):187–194.
16. Arabi A, El Rassi R, El-Hajj Fuleihan G: Hypovitaminosis D in developing
countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 2010,
6(10):550–561.
17. McBeth J, Pye SR, O’Neill TW, Macfarlane GJ, Tajar A, Bartfai G, Boonen S,
Bouillon R, Casanueva F, Finn JD, et al: Musculoskeletal pain is associated
with very low levels of vitamin D in men: results from the European
Male Ageing Study. Ann Rheum Dis 2010, 69(8):1448–1452.
18. Mosekilde L, Nielsen LR, Larsen ER, Moosgaard B, Heickendorff L: Vitamin D
deficiency. Definition and prevalence in Denmark. Ugeskr Laeger 2005,
167(1):29–33.
19. Plotnikoff GA, Quigley JM: Prevalence of severe hypovitaminosis D in
patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc
2003, 78(12):1463–1470.
20. Al FS, Al MK: Vitamin D deficiency and chronic low back pain in Saudi
Arabia. Spine (Phila Pa 1976) 2003, 28(2):177–179.
21. Haroon M, Bond U, Quillinan N, Phelan MJ, Regan MJ: The prevalence of
vitamin D deficiency in consecutive new patients seen over a 6-month
period in general rheumatology clinics. Clin Rheumatol 2011,
30(6):789–794.
22. Heidari B, Shirvani JS, Firouzjahi A, Heidari P, Hajian-Tilaki KO: Association
between nonspecific skeletal pain and vitamin D deficiency. Int J Rheum
Dis 2010, 13(4):340–346.23. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA:
Hypovitaminosis D in female patients with chronic low back pain.
Clin Rheumatol 2007, 26(11):1895–1901.
24. Mosekilde L: Primary hyperparathyroidism and the skeleton.
Clin Endocrinol (Oxf ) 2008, 69(1):1–19.
25. Manniche C, Asmussen K, Lauritsen B, Vinterberg H, Kreiner S, Jordan A:
Low back pain rating scale: validation of a tool for assessment of low
back pain. Pain 1994, 57(3):317–326.
26. Jensen TS, Sorensen JS, Kjaer P: Intra- and interobserver reproducibility of
vertebral endplate signal (modic) changes in the lumbar spine: the
Nordic Modic Consensus Group classification. Acta Radiol 2007,
48(7):748–754.
27. Fodevareinstituttet D: D-vitamin. Opdatering af videnskabelig evidens for
sygdomsforebyggelse og anbefalinger. first edition. Soborg, Denmark; 2010.
28. Lips P: Which circulating level of 25-hydroxyvitamin D is appropriate?
J Steriod Biochem Mol Biol 2004, 89–90(1–5):611–614.
29. Consultancy DRaM: Sample Size Calculator. 2012. Available at http://www.
dimensionsintl.com/research_services/research_tools/sample_calculator.
html, access date: 3rd August 2011.
30. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P,
Eriksen EF: Commonly recommended daily intake of vitamin D is not
sufficient if sunlight exposure is limited. J Intern Med 2000,
247(2):260–268.
31. Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sorensen OH:
Vitamin D status and its adequacy in healthy Danish perimenopausal
women: relationships to dietary intake, sun exposure and serum
parathyroid hormone. Br J Nutr 2001, 86(Suppl 1):S97–S103.
32. Grebe SK, Singh RJ: LC-MS/MS in the clinical laboratory - where to from
here? Clin Biochem Rev 2011, 32(1):5–31.
33. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF: An international
comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int
1999, 9(5):394–397.
34. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF: Decreased
bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72(3):690–693.
35. Straube S, Derry S, Moore RA, McQuay HJ: Vitamin D for the treatment of
chronic painful conditions in adults. Cochrane Database Syst Rev 2010,
1:CD007771.
36. Deyo RA, Weinstein JN: Low back pain. N Engl J Med 2001, 344(5):363–370.
37. Ramond A, Bouton C, Richard I, Roquelaure Y, Baufreton C, Legrand E, Huez
JF: Psychosocial risk factors for chronic low back pain in primary care–a
systematic review. Fam Pract 2011, 28(1):12–21.
doi:10.1186/1471-2474-14-78
Cite this article as: Johansen et al.: Vitamin D levels appear to be normal
in Danish patients attending secondary care for low back pain and a
weak positive correlation between serum level Vitamin D and Modic
changes was demonstrated: a cross-sectional cohort study of
consecutive patients with non-specific low back pain. BMC
Musculoskeletal Disorders 2013 14:78.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
